Synopsis and data synthesis of genetic association studies in hypertension for the adrenergic receptor family genes: the CUMAGAS-HYPERT database - PubMed (original) (raw)

Synopsis and data synthesis of genetic association studies in hypertension for the adrenergic receptor family genes: the CUMAGAS-HYPERT database

Georgios D Kitsios et al. Am J Hypertens. 2010 Mar.

Abstract

Background: The adrenergic receptor (adrenoceptor) family genes have been extensively studied as candidate genes in hypertension but the results of individual genetic association studies (GAS) are controversial and inconclusive. To clarify these data, a systematic assessment of GAS for adrenoceptor family genes in hypertension was conducted.

Methods: Data from 163 GAS involving 7 genes and 37 distinct genetic variants were analyzed and cataloged in CUMAGAS-HYPERT (Cumulative Meta-analysis of Genetic Association Studies-HYPERTension; a web-based information system, which allows the retrieval and synthesis of data from GAS in hypertension, available at http://biomath.med.uth.gr). Data from genome-wide association studies involving the adrenoceptor family genes were also systematically searched.

Results: Individual GAS reported inconsistent associations and had limited power to detect modest genetic effects, with only 1.2% having power >80%. Thirteen variants were investigated by three or more studies and their results were subject to meta-analysis. In the main meta-analyses, significant results were shown for five variants (ADRB1 p.Arg389Gly, ADRB1 p.Ser49Gly, ADRB2 g.9368308A>G, ADRB3 p.Trp64Arg, and ADRA1A p.Cys347Arg) under the allelic contrast and/or the dominant model. Subgroup analyses by ethnicity and gender detected significant associations for three variants (ADRB1 p.Arg389Gly in east Asians, ADRB2 p.Gln27Glu in whites, and ADRB3 p.Trp64Arg in whites and in males). Heterogeneity ranged from none to high. No significant associations were recorded from genome-wide studies.

Conclusions: There is evidence to implicate adrenoceptor genes in hypertension, although future studies designed to investigate epistatic and gene-environment interactions would allow more solid conclusions to be drawn about the role of these genes in hypertension.

PubMed Disclaimer

Figures

Figure 1

Flow chart of studies retrieved and studies excluded, with specification of reasons.

Comment in

Sympathetic meta-analysis of adrenoceptor gene variants in hypertension.
Morris BJ. Morris BJ. Am J Hypertens. 2010 Mar;23(3):225. doi: 10.1038/ajh.2009.267. Am J Hypertens. 2010. PMID: 20154653 No abstract available.

Cited by

Unraveling the relationships between alpha- and beta-adrenergic modulation and the risk of heart failure.
Baudier C, Fougerousse F, Asselbergs FW, Guedj M, Komajda M, Kotecha D, Thomas Lumbers R, Schmidt AF, Tyl B. Baudier C, et al. Front Cardiovasc Med. 2023 Oct 18;10:1148931. doi: 10.3389/fcvm.2023.1148931. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37920183 Free PMC article.
Computational resources associating diseases with genotypes, phenotypes and exposures.
Zhang W, Zhang H, Yang H, Li M, Xie Z, Li W. Zhang W, et al. Brief Bioinform. 2019 Nov 27;20(6):2098-2115. doi: 10.1093/bib/bby071. Brief Bioinform. 2019. PMID: 30102366 Free PMC article.
ADRB3 Gene Trp64Arg Polymorphism and Essential Hypertension: A Meta-Analysis Including 9,555 Subjects.
Li YY, Lu XZ, Wang H, Zhou YH, Yang XX, Geng HY, Gong G, Kim HJ. Li YY, et al. Front Genet. 2018 Apr 4;9:106. doi: 10.3389/fgene.2018.00106. eCollection 2018. Front Genet. 2018. PMID: 29670643 Free PMC article.
Germline genetic variants with implications for disease risk and therapeutic outcomes.
Pasternak AL, Ward KM, Luzum JA, Ellingrod VL, Hertz DL. Pasternak AL, et al. Physiol Genomics. 2017 Oct 1;49(10):567-581. doi: 10.1152/physiolgenomics.00035.2017. Epub 2017 Sep 8. Physiol Genomics. 2017. PMID: 28887371 Free PMC article. Review.
A common hypofunctional genetic variant of GPER is associated with increased blood pressure in women.
Feldman RD, Gros R, Ding Q, Hussain Y, Ban MR, McIntyre AD, Hegele RA. Feldman RD, et al. Br J Clin Pharmacol. 2014 Dec;78(6):1441-52. doi: 10.1111/bcp.12471. Br J Clin Pharmacol. 2014. PMID: 25039431 Free PMC article.

References

1. Cowley AW., Jr The genetic dissection of essential hypertension. Nat Rev Genet. 2006;7:829–840. - PubMed
1. Binder A. A review of the genetics of essential hypertension. Curr Opin Cardiol. 2007;22:176–184. - PubMed
1. Hamet P, Seda O. Current status of genome-wide scanning for hypertension. Curr Opin Cardiol. 2007;22:292–297. - PubMed
1. Zintzaras E, Kitsios G, Kent D, Camp NJ, Atwood L, Hopkins PN, Hunt SC. Genome-wide scans meta-analysis for pulse pressure. Hypertension. 2007;50:557–564. - PubMed
1. DeQuattro V, Feng M. The sympathetic nervous system: the muse of primary hypertension. J Hum Hypertens. 2002;16(Suppl 1):S64–S69. - PubMed

Synopsis and data synthesis of genetic association studies in hypertension for the adrenergic receptor family genes: the CUMAGAS-HYPERT database - PubMed (original) (raw)